Healthcare provider profile · identity verified

Jill Louise Studley

Geriatric Medicine · DALLAS, TX · NPI 1023049053

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	474	137
Atorvastatin Calcium	Atorvastatin Calcium	409	115
Amlodipine Besylate	Amlodipine Besylate	307	94
Simvastatin	Simvastatin	227	61
Pantoprazole Sodium	Pantoprazole Sodium	225	73
Losartan Potassium	Losartan Potassium	220	67
Lisinopril	Lisinopril	210	67
Metoprolol Succinate	Metoprolol Succinate	207	65
Gabapentin	Gabapentin	190	58
Rosuvastatin Calcium	Rosuvastatin Calcium	181	54
Escitalopram Oxalate	Escitalopram Oxalate	167	54
Omeprazole	Omeprazole	156	47
Furosemide	Furosemide	146	49
Carvedilol	Carvedilol	141	40
Donepezil Hcl	Donepezil Hcl	140	40
Tamsulosin Hcl	Tamsulosin Hcl	135	40
Potassium Chloride	Potassium Chloride	128	46
Mirtazapine	Mirtazapine	124	42
Eliquis	Apixaban	123	33
Metformin Hcl	Metformin Hcl	122	38
Trazodone Hcl	Trazodone Hcl	119	36
Synthroid	Levothyroxine Sodium	108	28
Memantine Hcl	Memantine Hcl	105	26
Pravastatin Sodium	Pravastatin Sodium	104	34
Sertraline Hcl	Sertraline Hcl	103	34
Duloxetine Hcl	Duloxetine Hcl	102	27
Allopurinol	Allopurinol	84	22
Januvia	Sitagliptin Phosphate	83	15
Hydrochlorothiazide	Hydrochlorothiazide	81	19
Metoprolol Tartrate	Metoprolol Tartrate	78	23
Prednisone	Prednisone	71	32
Clopidogrel	Clopidogrel Bisulfate	63	19
Estradiol	Estradiol	63	25
Venlafaxine Hcl Er	Venlafaxine Hcl	61	14
Famotidine	Famotidine	60	25
Myrbetriq	Mirabegron	58	24
Citalopram Hbr	Citalopram Hydrobromide	57	17
Meloxicam	Meloxicam	56	22
Alprazolam	Alprazolam	55	20
Tramadol Hcl	Tramadol Hcl	55	21
Finasteride	Finasteride	50	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	14
Ipratropium Bromide	Ipratropium Bromide	47	25
Albuterol Sulfate Hfa	Albuterol Sulfate	44	16
Fluticasone Propionate	Fluticasone Propionate	44	23
Alendronate Sodium	Alendronate Sodium	43	12
Atenolol	Atenolol	43	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	18
Ezetimibe	Ezetimibe	41	15
Spironolactone	Spironolactone	40	12
Lovastatin	Lovastatin	39	11
Montelukast Sodium	Montelukast Sodium	38	12
Quetiapine Fumarate	Quetiapine Fumarate	38	11
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Irbesartan	Irbesartan	36	suppressed
Lorazepam	Lorazepam	32	suppressed
Azithromycin	Azithromycin	31	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Primidone	Primidone	26	suppressed
Ramipril	Ramipril	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	22
Bisoprolol Fumarate	Bisoprolol Fumarate	25	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Ondansetron Odt	Ondansetron	24	14
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Valsartan	Valsartan	24	suppressed
Cefuroxime	Cefuroxime Axetil	23	18
Sucralfate	Sucralfate	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Glipizide	Glipizide	20	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Ozempic	Semaglutide	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Armour Thyroid	Thyroid,pork	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Nystatin	Nystatin	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error